Abstract
Bacterial infection is one of the major causes of morbidity and mortality especially in developing countries. The aim of this study was to develop a new radiopharmaceutical for imaging infection. The labeling conditions were optimized, and lyophilized kits were developed for instant preparing. The stability of 99mTc-AMOX in human serum was identified, sterility and pyrogenicity of the radiopharmaceutical were estimated, gamma scintigraphy and in vivo biodistribution with infected rats were investigated. The promising properties of 99mTc-AMOX combined with the development of reliable and instant lyophilized kit afford the opportunity of inflammatory process imaging.
Similar content being viewed by others
References
El-Ghany EA, El-Kolaly T, Amine AM, El-Sayed AS, Abdel-Gelil F (2005) Synthesis of 99mTc-pefloxacin: a new targeting agent forinfectious foci. J Radioanal Nucl Chem 266:131–139
Das SS, Hall AV, Wareham DDW, Britton KE (2002) Infection imaging with radiopharmaceuticals in the 21st century. Braz Arch Biol Technol. 45:25–37
Shah SQ, Khanb MR (2012) Radiosynthesis of 99mTc-Labeled Novobiocin Dithiocarbamate Complex as a Potential Staphylococcus aureus Infection Radiotracer. Radiochemistry 54(3):279–283
Nibbering PH, Welling MM, Paulusma-Annema A, Brouwer CPJM, Lupetti A, Pauwels EKJ (2004) 99mTc-Labeled UBI 29-41 Peptide for Monitoring the Efficacy of Antibacterial Agents in Mice Infected with Staphylococcus aureus. J Nucl Med 45:321–326
Kaul A, Hazari PP, Rawat H, Singh B, Kalawat TC, Sharma S, Babbar AK, Mishra AK (2013) Preliminary evaluation of technetium-99m-labeled ceftriaxone: infection imaging agent for the clinical diagnosis of orthopedic infection. Int J Infect Dis. 17(4):e263–e270
Gemmel F, Dumarey N, Welling M (2009) Future diagnostic agents. Semin Nucl Med 39:11–26
Fazli A, Saluti M, Ahmadi Gh, Mirshojaei F, Mazidi M, Heydari Z (2012) Radiolabeling of ceftriaxone with 99mTc as a targeting radiopharmaceutical for staphylococcus aureus detection in mouse model. Iran J Med Phys 9(2):103–110
Britton KE, Wareham DW, Das SS, Solanki KK, Amaral H et al (2002) Imaging bacterial infection with 99mTc-ciprofloxacin (Infecton). J Clin Pathol 55(11):817–823
Britton KE, Vinjamuri S, Hall AV, Solanki K, Siraj QH, Bomanji J, Das S (1997) Clinical evaluation of technetium-99m infecton for the localisation of bacterial infection. Eur J Nucl Med 24(5):553–556
Pauwels EK, Welling MM, Lupetti A, Nibbering PH (2001) Concerns about 99mTc-labelled ciprofloxacin for infection detection—reply. Eur J Nucl Med 28:781
Signore A, D’Alessandria C, Lazzeri E, Dierck R (2008) Can we produce an image of bacteria with radiopharmaceuticals? Eur J Nucl Med Mol Imaging 35:1051–1055
Çağlayan Örümlü O (2010) Development new radiopharmaceutics for imaging acute infection and inflammation, (PhD Thesis), Ege University Radiopharmacy Department, İzmir
Örümlü O, Aşıkoğlu M (2004) Labelling od Amoxicillin Sodium with 99mTc’. In: The 4th international postgraduate research symposium on pharmaceuticals’, Istanbul. 20–22 Sept 2004
http://www.medicines.ie/medicine/2183/SPC/Augmentin+Intravenous+1.2g/
Acknowledgments
This study was supported by The Scientific and Technological Research Council of Turkey (Tubitak-110 S 229). The authors would like to acknowledge the support of T.R. Prime Ministry State Planning Organization Foundation Grant Project Number: 09DPT001 for TLC Scanner. Also the authors thank to Ege University Nuclear Medicine Department technicians for their technical assistance for the animal experiments.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ilem-Ozdemir, D., Caglayan-Orumlu, O., Asikoglu, M. et al. Evaluation of 99mTc-amoxicillin sodium as an infection imaging agent in bacterially infected and sterile inflamed rats. J Radioanal Nucl Chem 308, 995–1004 (2016). https://doi.org/10.1007/s10967-015-4516-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-015-4516-4